期刊文献+

二尖瓣手术联合冠状动脉搭桥治疗缺血性二尖瓣反流的Meta分析 被引量:1

Effect of Mitral Valve Surgery Combined with Coronary Artery Bypass Graft on Ischemic Mitral Regurgitation: A Meta-analysis
下载PDF
导出
摘要 目的运用循证医学方法探讨二尖瓣手术(MVS)联合冠状动脉搭桥术(CABG)治疗中重度缺血性二尖瓣反流(IMR)的疗效。方法计算机检索OVID、MEDLINE、EMBASE、Web of Science、Cochrane Liborary等数据库中有关CABG及CABG+MVS治疗中重度IMR患者的临床研究,采用Stata 12.0软件进行Meta分析。结果共纳入9个非随机试验和1个随机对照试验,其中CABG组1 549例,CABG+MVS组1 002例。Meta分析结果显示,MVS+CABG与CABG组远期死亡率、术后远期纽约心功能分级比较,差异无统计学意义(P>0.05);MVS+CABG在改善远期二尖瓣反流分级方面优于CABG(P<0.05)。结论在治疗中重度IMR方面是否有必要联合CABG与MVS仍需要更多的临床研究证实。 Objective To investigate the effect of mitral valve surgery( MVS) combined with coronary artery bypass graft( CABG) on moderate,severe ischemic mitral regurgitation( IMR) with the method of evidence-based medicine.Methods The databases including OVID,MEDLINE,EMBASE,Web of Science,Cochrane Library were retrieved for the relevant clinical trials on CABG and CABG plus MVS for the treatment of moderate,severe IMR patients. Stata 12. 0 software was applied to a Meta-analysis. Results Nine non-randomized trials and 1 randomized controlled trial were included,1 549 cases in the CABG group,1002 cases in the CABG plus MVS group. The results of Meta-analysis were as follows. There were no significant differences in the long-term mortality,long-term postoperative NYHA heart function classification between CABG plus MVS group and CABG group( P〉0. 05). CABG plus MVS was superior to CABG in terms of the long-term mitral regurgitation grade( P〈0. 05). Conclusion More clinical studies are needed to demonstrate the necessity of applying CABG combined with MVS to the treatment of moderate to severe IMR.
出处 《广西医学》 CAS 2014年第11期1573-1576,共4页 Guangxi Medical Journal
基金 广东省佛山市顺德区医学科学技术研究计划(2012073)
关键词 缺血性二尖瓣反流 二尖瓣手术 冠状动脉搭桥术 META分析 Ischemic mitral regurgitation Mitral valve surgery Coronary artery bypass graft Meta-analysis
  • 相关文献

参考文献15

  • 1Simpson IA, Shiota T, Gharib M, et al. Current status of flow convergence for clinical applications:is it a leaning tower of "PISA"? [J].J Am Coll Cardiol,1996,27(2) :504 -509.
  • 2Enriquez-Sarano M, Miller FA Jr, Hayes SN, et al. Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method[ J ]. J Am Coll Cardiol, 1995,25 (3) :703 - 709.
  • 3Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting i- tems for systematic reviews and recta-analyses : the PRISMA statement[J]. Int J Surg,2010,8(5) :336 -341.
  • 4Egger M, Davey Smith G, Schneider M, et al. Bias in meta- analysis detected by a simple, graphical test [ J ]. BMJ, 1997,315(7 109) 629-634.
  • 5Wong DR, Agnihotri AK, Hung JW, et al. Long-term survival after surgical revascularization for moderate ischemic mitral regurgitation [ J ]. Ann Thorac Surg, 2005,80 (2) : 570 - 577.
  • 6Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in pa- tients with functional ischemic mitral regurgitation[ J]. J Am Coil Cardiol,2007,49(22) :2 191 -2 201.
  • 7Diodato MD, Moon MR, Pasque MK, et al. Repair of ische- mic mitral regurgitation does not increase mortality or im- prove long-term survival in patients undergoing coronary ar- tery revascularization:a propensity analysis[ J]. Ann Thorac Surg,2004,78 (3) :794 - 799.
  • 8Buja P,Tarantini G,Del Bianco F ,et al. Moderate-to-severe ischemic mitral regurgitation and multivessel coronary artery disease:Impact of different treatment on survival and rehos- pitalization [ J ]. Int J Cardiol,2006,111 ( 1 ) :26 - 33.
  • 9Trichon BH, Glower DD, Shaw LK, et al. Survival after coro- nary revascularization, with and without mitral valve surger- y, in patients with ischemic mitral regurgitation [ J ]. Circula- tion ,2003,108 ( Suppl 1 ) : 103 - 110.
  • 10Kang DH, Kim MJ, Kang SJ, et al. Mitral valve repair versus revascularization alone in the treatment of ischemic mitral re- gurgitation[J]. Circulation,2006,114(Suppl 1 ) :1 499 - 1 503.

同被引文献14

  • 1Park S J, Kim Y H, Park D W. Randomized trial of stents versus bypass surgery for left main coronary artery disease[J]. New England Journal of Medicine, 2011, 364(18) :1718- 1727.
  • 2Costa F, Ariotti S, Valgimigli M, et al. Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading? [J]. Journal of Cardiovascular Translational Research, 2015, 8(4).
  • 3Serruys P W. Pereutaneous Coronary Interventionversus Coronary- Artery Bypass Grafting - NEJM [J].New England Journal of Medicine.
  • 4KeelingW B, Kilgo P D, Puskas J D, et al. Of{- pump coronary artery bypass grafting attenuates mor- bidity and mortality for patients with low and high body mass index[J]. Journal of Thoracic ~ Cardio- vascular Surgery, 2013, 146(6) : 1442 - 1448.
  • 5Deja M A, Grayburn P A, Sun B, et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. [J]. Circula-tion, 2012, 125(21):2639 - 2648.
  • 6Patel N C, Deodhar A P, Grayson A D, et al. Neu- rological outcomes in coronary surgery: independent effect of avoiding cardiopulmonary bypass[J]. Annals of Thoracic Surgery, 2002, 74(2) :400 - 406.
  • 7Biancari F, Vasques F, Mikkola R, et al. Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery[J].Annals of Thoracic Sur- gery, 2012, 93(6):1930-1935.
  • 8苏丕雄,刘岩,顾松,颜钧,张希涛,赵洋.SinoSCORE对CABG术后死亡和并发症的预测价值[J].中华胸心血管外科杂志,2011,27(2):71-74. 被引量:9
  • 9白云鹏,刘建实,陈庆良,郭志刚,姜楠,王联群,李培军.7种危险评分系统对CABG术后病死率预测效能的比较[J].中华胸心血管外科杂志,2012,28(3):152-156. 被引量:5
  • 10孙勇新,丁文军,夏利民,王春生.高危冠心病患者体外和非体外循环冠状动脉旁路移植术近期疗效比较[J].中华胸心血管外科杂志,2012,28(6):352-355. 被引量:20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部